Transcatheter arterial chemoembolization and percutaneous ethanol injection for hepatocellular carcinoma: A retrospective review of the Veterans Affairs Caribbean Healthcare System

Cancer Control

Volumn 15, Issue 1, 2008, Pages 80-85

  Narvaez Lugo, Jessica ^a,b   Cáceres, William W ^a   Toro, Doris H ^a   Pérez González, Manuel R ^a   Almodovar, Alvin A ^a   Maldonado Mercado, Awilda M ^a   Salgado, Norma ^a   Rivera Sanfeliz, Gerant M ^a,c  

^a VA Caribbean Healthcare System Puerto Rico   (Puerto Rico)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CENTRAL AMERICA; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE SYSTEM; HEPATITIS C; HEPATOGRAPHY; HUMAN; HUMAN TISSUE; INFECTION; INJECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; MALE; PATIENT ASSESSMENT; PUERTO RICO; RATING SCALE; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR NECROSIS; TUMOR VOLUME; VETERAN; INTRADERMAL DRUG ADMINISTRATION; KAPLAN MEIER METHOD; LIVER TUMOR; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; SURVIVAL;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; ETHANOL; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 40749143185     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327480801500110     Document Type: Article

References (20)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
2. Romeo R, Colombo M. The natural history of hepatocellular carcinoma. Toxicology. 2002;181-182:39-42.
3. Nagasue N, Yukaya H, Hamada T, et al. The natural history of hepatocellular carcinoma: a study of 100 untreated cases. Cancer. 1984;54:1461-1465.
4. Iwatsuki S, Starzl TE. Experience with resection of primary hepatic malignancy. Surg Clin North Am. 1989;69:315-322.
5. Lencioni RA. Approach to diagnosis and management of lesions detected by hepatocellular carcinoma surveillance programs. ASCO Educational Book. 2006;241-244.
6. Stuart K. Chemoembolization in the management of liver tumors. Oncologist. 2003;8:425-437.
7. Ngan H, Lai CL, Fan ST, et al. Transcatheter arterial chemoembolization in inoperable hepatocellular carcinoma: four-year follow-up. J Vasc Interv Radiol. 1996;7:419-425.
8. Yamakado K, Nakatsuka A, Tanaka N, et al. Long-term follow-up of arterial chemoembolization combined with transportal ethanol injection used to treat hepatocellular carcinoma. J Vasc Interv Radiol. 1999;10:641-647.
9. de Baère T, Denys A, Briquet R, et al. Modification of arterial and portal hemodynamics after injection of iodized oils and different emulsions of iodized oils in the hepatic artery: an experimental therapy. J Vasc Interv Radiol. 1998;9:305-310.
10. Yarbro J, Bornstein R, Mastrangelo M. Treatment of liver cancer. Semin Oncol. 1997;24:S6,142.
11. Lee HS, Kim KM, Yoon JH, et al. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study. J Clin Oncol. 2002;20:4459-4465.
12. Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology. 2005;129:123-130.
13. Pérez CM, Suárez E, Torres EA, et al. Seroprevalence of hepatitis C virus and associated risk behaviours: a population-based study in San Juan, Puerto Rico. Int J Epidemiol. 2005;34:593-599. Epub 2005 Mar 31.
14. Bruix J, Castells A, Bosch J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996;111:1018-1022.
15. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatments for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434-1440.
16. Shiina S, Tagawa K, Niwa Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol. 1993:160:1023-1028.
17. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. carcinoma. Hepatology. 2002;35:1164-1171.
18. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734-1739.
19. Steel J, Baum A, Carr B. Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of cisplatin versus 90-yttrium microspheres (Therasphere). Psychooncology. 2004;13:73-79.
20. Ebied OM, Federle MP, Carr BI, et al. Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma. Cancer. 2003;97:1042-1050.